Patents by Inventor Adrienne Kovacsne-Mezei

Adrienne Kovacsne-Mezei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Forms of tiotropium bromide and processes for preparation thereof
    Patent number: 9108962
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: August 18, 2015
    Assignee: Sicor, Inc.
    Inventors: Nicola Diulgheroff, Francesca Scarpitta, Alessandro Pontiroli, Adrienne Kovacsne-Mezei, Judith Aronhime, Alexandr Jegorov
  • Novel Forms Of Tiotropium Bromide And Processes For Preparation Thereof
    Publication number: 20140323515
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Application
    Filed: June 16, 2014
    Publication date: October 30, 2014
    Inventors: Nicola DIULGHEROFF, Francesca SCARPITTA, Alessandro PONTIROLI, Adrienne KOVACSNE-MEZEI, Judith ARONHIME, Alexandr JEGOROV
  • Forms of tiotropium bromide and processes for preparation thereof
    Patent number: 8846926
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: September 30, 2014
    Assignee: Sicor Inc.
    Inventors: Nicola Diulgheroff, Francesca Scarpitta, Alessandro Pontiroli, Adrienne Kovacsne-Mezei, Judith Aronhime, Alexandr Jegorov
  • Solid state forms of fidaxomycin and processes for preparation thereof
    Patent number: 8722863
    Abstract: The present invention provides solid state forms of Fidaxomycin, processes for preparing the solid state forms, as well as pharmaceutical compositions and formulations comprising one or more of the solid state forms of Fidaxomycin, and processes for the preparation of the compositions and formulations. The solid state forms of the present invention exhibit advantageous properties such as improved reliability and reproducibility in manufacturing and processing and stability in formulations.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: May 13, 2014
    Assignee: Teva Pharmaceutical Works Ltd.
    Inventors: Tamas Fonagy, Adrienne Kovacsne-Mezei, Levente Szuros, Edit Nagyne Arvai
  • Solid State Forms Of Fidaxomycin And Processes For Preparation Thereof
    Publication number: 20140128334
    Abstract: The present invention provides solid state forms of Fidaxomycin, processes for preparing the solid state forms, as well as pharmaceutical compositions and formulations comprising one or more of the solid state forms of Fidaxomycin, and processes for the preparation of the compositions and formulations. The solid state forms of the present invention exhibit advantageous properties such as improved reliability and reproducibility in manufacturing and processing and stability in formulations.
    Type: Application
    Filed: October 31, 2013
    Publication date: May 8, 2014
    Applicant: Teva Pharmaceutical Works Ltd.
    Inventors: Tamas FONAGY, Adrienne KOVACSNE-MEZEI, Levente SZUROS, Edit Nagyne ARVAI
  • NOVEL FORMS OF TIOTROPIUM BROMIDE AND PROCESSES FOR PREPARATION THEREOF
    Publication number: 20140057935
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Application
    Filed: October 31, 2013
    Publication date: February 27, 2014
    Applicant: SCIOR INC.
    Inventors: Nicola Diulgheroff, Francesca Scarpitta, Alessandro Pontiroli, Adrienne Kovacsne-Mezei, Judith Aronhime, Alexander Jegorov
  • SOLID STATE FORMS OF FIDAXOMYCIN AND PROCESSES FOR PREPARATION THEREOF
    Publication number: 20130303472
    Abstract: The present invention provides solid state forms of Fidaxomycin, processes for preparing the solid state forms, as well as pharmaceutical compositions and formulations comprising one or more of the solid state forms of Fidaxomycin, and processes for the preparation of the compositions and formulations. The solid state forms of the present invention exhibit advantageous properties such as improved reliability and reproducibility in manufacturing and processing and stability in formulations.
    Type: Application
    Filed: May 17, 2013
    Publication date: November 14, 2013
    Inventors: Tamas FONAGY, Adrienne KOVACSNE-MEZEI, Levente SZUROS, Edit Nagyne ARVAI
  • NOVEL FORMS OF TIOTROPIUM BROMIDE AND PROCESSES FOR PREPARATION THEREOF
    Publication number: 20120165364
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Application
    Filed: March 5, 2012
    Publication date: June 28, 2012
    Applicant: SICOR INC.
    Inventors: Nicola Diulgheroff, Francesca Scarpitta, Alessandro Pontiroli, Adrienne Kovacsne-Mezei, Judith Aronhime, Alexandr Jegorov
  • NOVEL FORMS OF TIOTROPIUM BROMIDE AND PROCESSES FOR PREPARATION THEREOF
    Publication number: 20120108625
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Application
    Filed: December 28, 2011
    Publication date: May 3, 2012
    Applicant: SICOR INC.
    Inventors: Nicola DIULGHEROFF, Francesca SCARPITTA, Alessandro PONTIROLI, Adrienne KOVACSNE-MEZEI, Judith ARONHIME, Alexandr JEGOROV
  • Forms of tiotropium bromide and processes for preparation thereof
    Patent number: 8163913
    Abstract: This invention relates to novel crystalline forms of tiotropium bromide, processes for preparing them, and their use in pharmaceutical formulations.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: April 24, 2012
    Assignee: Sicor Inc.
    Inventors: Nicola Diulgheroff, Francesca Scarpitta, Alessandro Pontiroli, Adrienne Kovacsne-Mezei, Judith Aronhime, Alexandr Jegorov
  • Polymorphs of fluticasone furoate and process for preparation thereof
    Patent number: 8148353
    Abstract: Provided are polymorphs of fluticasone furoate and processes for preparation thereof.
    Type: Grant
    Filed: August 6, 2009
    Date of Patent: April 3, 2012
    Assignee: Plus Chemicals SA
    Inventors: Peter Lindsay MacDonald, Pierluigi Rossetto, Adrienne Kovacsne-Mezei, Roman Gabriel, Alexandr Jegorov, Jiri Faustmann
  • POLYMORPHS OF FLUTICASONE FUROATE AND PROCESSES FOR PREPARATION THEREOF
    Publication number: 20100240629
    Abstract: The present invention provides crystalline forms of Fluticasone furoate, characterized by the data disclosed in the specification; pharmaceutical compositions comprising any one or combination of the crystalline forms of Fluticasone furoate and at least one pharmaceutically acceptable excipient; and the use of the crystalline forms of Fluticasone furoate in the preparation of pharmaceutical formulations.
    Type: Application
    Filed: March 19, 2010
    Publication date: September 23, 2010
    Inventors: Adrienne KOVACSNE-MEZEI, Roman Gabriel, Alexandr Jegorov
  • DESLORATADINE CRYSTALLINE FORMS MIXTURES HAVING A LOW LEVEL OF RESIDUAL SOLVENTS
    Publication number: 20100216831
    Abstract: Provided are desloratadine mixtures, comprising a low level of residual solvents and processes for the preparation thereof.
    Type: Application
    Filed: November 17, 2006
    Publication date: August 26, 2010
    Applicant: Teva Pharmaceutical Industries, Ltd.
    Inventors: Zoltan Toth, Piroska Kovacs, Csaba Peto, Adrienne Kovacsne Mezei
  • Polymorphs of fluticasone furoate and process for preparation thereof
    Publication number: 20100130458
    Abstract: Provided are polymorphs of fluticasone furoate and processes for preparation thereof.
    Type: Application
    Filed: August 6, 2009
    Publication date: May 27, 2010
    Inventors: Peter Lindsay Macdonald, Pierluigi Rossetto, Adrienne Kovacsne-Mezei, Roman Gabriel, Alexandr Jegorov, Jiri Faustmann
  • Polymorphs of atomoxetine hydrochloride
    Publication number: 20100076225
    Abstract: The present invention provides novel crystalline polymorph forms of atomoxetine hydrochloride denominated Forms B and C and methods for their preparation, as well as methods for the preparation of Form A. The present invention provides pharmaceutical compositions that comprise atomoxetine hydrochloride Form B, Form C, or mixtures thereof that can be used to treat attention deficit/hyperactivity disorder.
    Type: Application
    Filed: December 3, 2009
    Publication date: March 25, 2010
    Inventors: Judith Aronhime, Stefano Bianchi, Eugenio Castelli, Paola Daverio, Silvia Mantovani, Adrienne Kovacsne-Mezei
  • Processes for producing crystalline macrolides
    Patent number: 7645876
    Abstract: The present invention provides processes for crystallization of macrolides, specifically pimecrolimus and tacrolimus.
    Type: Grant
    Filed: December 1, 2005
    Date of Patent: January 12, 2010
    Assignee: TEVA Gyógyszergyár Zártkörúen Müködö Részvénytársaság
    Inventors: Vilmos Keri, Istvan Melczer, Adrienne Kovacsne-Mezei
  • Production of dolasetron
    Patent number: 7608714
    Abstract: The present invention provides an improved process for the preparation of Dolasetron salts, in particularly Dolasetron mesylate. Also provided are intermediates for the process and methods of preparing the intermediates.
    Type: Grant
    Filed: January 5, 2007
    Date of Patent: October 27, 2009
    Assignee: TEVA Gyógyszergyár Zártkörúen Müködö Részvénytársaság
    Inventors: Janos Hajko, Tivadar Tamas, Adrienne Kovacsne-Mezei, Erika Magyar Molnarne, Csaba Peto, Csaba Szabo
  • Non-hygroscopic and powdery amorphous pimecrolimus
    Patent number: 7589100
    Abstract: An amorphous pimecrolimus and processes for providing an amorphous pimecrolimus are provided.
    Type: Grant
    Filed: December 1, 2005
    Date of Patent: September 15, 2009
    Assignee: TEVA Gyógyszergyár Zártkörún Müködö Részvénytársaság
    Inventors: Adrienne Kovacsne-Mezei, Csilla Nemethne Racz, Judith Aronhime, Csaba Szabo, Viktor Gyollai, Sandor Molnar, Micahel Pinchasov
  • Method of making dorzolamide hydrochloride
    Publication number: 20090137821
    Abstract: Processes for the preparation of dorzolamide hydrochloride and an intermediate of Formula IV, are provided.
    Type: Application
    Filed: December 22, 2008
    Publication date: May 28, 2009
    Inventors: Laszlo Zsolt Kovacs, Csaba Szabo, Erika Magyar Molnarne, Adrienne Kovacsne-Mezei, Claude Singer, Judith Aronhime
  • Dolasetron trifluoroacetate, polymorphs of dolasetron trifluoroacetate and process for preparation thereof
    Publication number: 20090062546
    Abstract: Provided are crystalline forms of dolasetron trifluoroacetate, methods for their preparation, and their use in preparing dolasetron mesylate.
    Type: Application
    Filed: July 21, 2008
    Publication date: March 5, 2009
    Inventors: Janos Hajko, Tivadar Tamas, Adrienne Kovacsne-Mezei, Piroska Kovacs